- Aflatoxin
- Deoxynivalenol
- Ochratoxins
- Fumonisins
- Trichothecene
- Zearalenone
- Patulin
- Others
The Europe Mycotoxin Testing Market size was valued at USD 242.9 million in 2023 and is poised to grow at a high CAGR of 11.3% from 2024 to 2030 to reach USD 513.9 million by 2028. Food rules are getting more stringent in Europe, and producers are being held to a higher standard, exposing various attempts to deceive customers. As a result, the European Union's Administrative Assistance and Cooperation System Food Fraud (AAC-FF), introduced in 2015, dedicates an IT tool that allows members of the EU Food Fraud Network to share information on non-compliances and potential intentional violations of EU Agri-food chain legislation.
As a result, Europeans, particularly Italians, have a higher proclivity to pay a higher average price for items that claim to have lower mycotoxin levels, underlining the need for food safety testing. For instance, However, the lack of standardization in collecting samples and the lack of infrastructure development in emerging countries hampers the Mycotoxin Testing Market. The Mycotoxin Testing Market is surging owing to frequent acquisitions and launchings by the market players. Strategic alliances by the players such as acquisitions, mergers, expansions and new product launches may enhance the company's growth.
Europe Mycotoxin Testing Market Key Developments:
In October 2020, Eurofins Scientific developed a novel method for identifying fructans in infant formulae and adult nutrition in partnership with Nestle Research (Lausanne, Switzerland). The approach has been given official standard status by the key standardization bodies, including the AOAC, ISO, CEN, and IDF.
Europe Mycotoxin Testing Market Dynamics
In 2021, Aflatoxin had a market revenue share of 18.9%, and from 2022 to 2028, it is predicted to increase at a CAGR of 10.9%. In 2021, Due to significant prevalence in agricultural goods used for human consumption, such as corn, peanuts, groundnuts, cotton seeds, and tree nuts, Aflatoxins held the largest market share in 2021. Chromatography based testing segment has a market share of 27.8% and is expected to increase at a CAGR of 11.3 % in the future years. The chromatography-based category has the biggest market share because the services involved in mycotoxin testing provide efficient testing using HPLC and LC chromatography, as well as their accuracy in content detection in analytical methods, which has contributed to their dominance in mycotoxin testing.
Country Analysis
Europe Mycotoxin Testing Market
Germany is predicted to have the largest share of the Mycotoxin Testing Market by 2028, and it is expected to grow rapidly in the following years. The food and feed testing mycotoxin policies have been strengthened by the contributed efforts from control laboratories (CLs), national reference laboratories (NRLs), and EU reference laboratories (EURLs). This market is additionally fuelled by the rising occurrence of fusarium toxins as a result of changing climatic conditions in the region.
Latin America
Europe
Asia Pacific
Middle East
North America
Europe Mycotoxin Testing Market Segmentation
By Type
By Sample
- Food
- Feed
By Technology
- Chromatography
- Spectroscopy and
- Immunoassay based
- North America
- Europe
- Asia Pacific
- Latin America
- MEA
Frequently Asked Questions
The mycotoxin testing market is projected to expand at a CAGR of 11.3% during the forecast period
SGS SA, Eurofins Scientific SE, Alta Bioscience, Romer Labs Division Holding GmbH, Intertek Group plc., ALS Limited, NEOGEN Corporation, EnviroLogix, TÜV SÜD, Fera Science Limited, SYNLAB International GmbH, R-Biopharm AG
Europe is the fastest-growing region for mycotoxin testing market
Key Features of the Report
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
| 1.Executive Summary |
| 2. Europe Bruton Tyrosine Kinase Inhibitors Market Introduction |
| 2.1. Europe Bruton Tyrosine Kinase Inhibitors Market - Taxonomy |
| 2.2. Europe Bruton Tyrosine Kinase Inhibitors Market - Definitions |
| 2.2.1.Type |
| 2.2.2.Sample |
| 2.2.3.Technology |
| 2.2.4.Country |
| 3. Europe Bruton Tyrosine Kinase Inhibitors Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Europe Bruton Tyrosine Kinase Inhibitors Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Europe Bruton Tyrosine Kinase Inhibitors Market By Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Aflatoxin |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Deoxynivalenol |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Ochratoxins |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Fumonisins |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Trichothecene |
| 5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Zearalenone |
| 5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 5.7. Patulin |
| 5.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.7.3. Market Opportunity Analysis |
| 5.8. Others |
| 5.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.8.3. Market Opportunity Analysis |
| 6. Europe Bruton Tyrosine Kinase Inhibitors Market By Sample, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Food |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Feed |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7. Europe Bruton Tyrosine Kinase Inhibitors Market By Technology, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Chromatography |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Spectroscopy and |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Immunoassay based |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8. Europe Bruton Tyrosine Kinase Inhibitors Market By Country, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Germany |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. France |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Italy |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. United Kingdom (UK) |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Spain |
| 8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.Germany Bruton Tyrosine Kinase Inhibitors Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Aflatoxin |
| 9.1.2.Deoxynivalenol |
| 9.1.3.Ochratoxins |
| 9.1.4.Fumonisins |
| 9.1.5.Trichothecene |
| 9.1.6.Zearalenone |
| 9.1.7.Patulin |
| 9.1.8.Others |
| 9.2. Sample Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Food |
| 9.2.2.Feed |
| 9.3. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Chromatography |
| 9.3.2.Spectroscopy and |
| 9.3.3.Immunoassay based |
| 10.France Bruton Tyrosine Kinase Inhibitors Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Aflatoxin |
| 10.1.2.Deoxynivalenol |
| 10.1.3.Ochratoxins |
| 10.1.4.Fumonisins |
| 10.1.5.Trichothecene |
| 10.1.6.Zearalenone |
| 10.1.7.Patulin |
| 10.1.8.Others |
| 10.2. Sample Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Food |
| 10.2.2.Feed |
| 10.3. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Chromatography |
| 10.3.2.Spectroscopy and |
| 10.3.3.Immunoassay based |
| 11.Italy Bruton Tyrosine Kinase Inhibitors Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Aflatoxin |
| 11.1.2.Deoxynivalenol |
| 11.1.3.Ochratoxins |
| 11.1.4.Fumonisins |
| 11.1.5.Trichothecene |
| 11.1.6.Zearalenone |
| 11.1.7.Patulin |
| 11.1.8.Others |
| 11.2. Sample Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Food |
| 11.2.2.Feed |
| 11.3. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Chromatography |
| 11.3.2.Spectroscopy and |
| 11.3.3.Immunoassay based |
| 12.United Kingdom (UK) Bruton Tyrosine Kinase Inhibitors Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Aflatoxin |
| 12.1.2.Deoxynivalenol |
| 12.1.3.Ochratoxins |
| 12.1.4.Fumonisins |
| 12.1.5.Trichothecene |
| 12.1.6.Zearalenone |
| 12.1.7.Patulin |
| 12.1.8.Others |
| 12.2. Sample Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Food |
| 12.2.2.Feed |
| 12.3. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Chromatography |
| 12.3.2.Spectroscopy and |
| 12.3.3.Immunoassay based |
| 13.Spain Bruton Tyrosine Kinase Inhibitors Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Aflatoxin |
| 13.1.2.Deoxynivalenol |
| 13.1.3.Ochratoxins |
| 13.1.4.Fumonisins |
| 13.1.5.Trichothecene |
| 13.1.6.Zearalenone |
| 13.1.7.Patulin |
| 13.1.8.Others |
| 13.2. Sample Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Food |
| 13.2.2.Feed |
| 13.3. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Chromatography |
| 13.3.2.Spectroscopy and |
| 13.3.3.Immunoassay based |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.SGS SA |
| 14.2.2.Eurofins Scientific SE |
| 14.2.3.Alta Bioscience |
| 14.2.4.Romer Labs Division Holding GmbH |
| 14.2.5.Intertek Group plc. |
| 14.2.6.ALS Limited |
| 14.2.7.NEOGEN Corporation |
| 14.2.8.EnviroLogix |
| 14.2.9.TÃœV SÃœD |
| 14.2.10.Fera Science Limited |
| 14.2.11.SYNLAB International GmbH |
| 14.2.12.R-Biopharm AG |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
- SGS SA
- Eurofins Scientific SE
- Alta Bioscience
- Romer Labs Division Holding GmbH
- Intertek Group plc.
- ALS Limited
- NEOGEN Corporation
- EnviroLogix
- TÃœV SÃœD
- Fera Science Limited
- SYNLAB International GmbH
- R-Biopharm AG